Clinical trials of disease-modifying agents in pediatric MS Opportunities, challenges, and recommendations from the IPMSSG

E Waubant, B Banwell, E Wassmer, MP Sormani, MP Amato, Rogier Hintzen, L Krupp, K Rostasy, S Tenembaum, T Chitnis

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)E2538-E2549
JournalNeurology
Volume92
Issue number22
DOIs
Publication statusPublished - 2019

Cite this